Top compounds associated with response to TLE2


Feature Type Standardized
Nominal ANOVA
mRNA RDEA119 GDSC1000 pan-cancer AAC -0.12 0.0003
mRNA Axitinib CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA PF-562271 GDSC1000 pan-cancer AAC -0.13 0.0004
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.0007
mRNA indisulam CTRPv2 pan-cancer AAC 0.11 0.0007
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC 0.13 0.0008
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.11 0.0009
mRNA gossypol CTRPv2 pan-cancer AAC 0.13 0.001
mRNA PD-0325901 GDSC1000 pan-cancer AAC -0.11 0.001
mRNA CHIR-99021 GDSC1000 pan-cancer AAC -0.11 0.001
Download CSV